Page 34 - JCBP-1-1

Journal of Clinical and
Basic Psychosomatics Relationship between PD and melanoma based on NHANES

5. Skibba JL, Pinckley J, Gilbert EF, et al., 1972, Multiple Parkinson’s disease and melanoma. Proc Natl Acad Sci U S A,
primary melanoma following administration of levodopa. 117: 22671 – 22673.
Arch Pathol, 93: 556 – 561.
https://doi.org/10.1073/pnas.2009702117
6. Bliss JM, Ford D, Swerdlow AJ, et al., 1995, Risk of cutaneous 15. Xu S, Chan P, 2015, Interaction between neuromelanin
melanoma associated with pigmentation characteristics and and alpha-synuclein in Parkinson’s disease. Biomolecules,
freckling: Systematic overview of 10 case-control studies. 5: 1122 – 1142.
The International Melanoma Analysis Group (IMAGE). Int
J Cancer, 62: 367 – 376. https://doi.org/10.3390/biom5021122
https://doi.org/10.1002/ijc.2910620402 16. Hu HH, Kannengiesser C, Lesage S, et al., 2016, Parkin
inactivation links Parkinson’s disease to melanoma. J Natl
7. Dong J, Gao J, Nalls M, et al., 2014, Susceptibility loci for Cancer Inst, 108: djv340.
pigmentation and melanoma in relation to Parkinson’s
disease. Neurobiol Aging, 35: 1512.e5 – 1512.e10. https://doi.org/10.1093/jnci/djv340
https://doi.org/10.1016/j.neurobiolaging.2013.12.020 17. Alvarez-Erviti L, Rodriguez-Oroz MC, Cooper JM, et al.,
2010, Chaperone-mediated autophagy markers in Parkinson
8. Gao X, Simon KC, Han J, et al., 2009, Genetic determinants disease brains. Arch Neurol, 67: 1464 – 1472.
of hair color and Parkinson’s disease risk. Ann Neurol,
65: 76 – 82. https://doi.org/10.1001/archneurol.2010.198
https://doi.org/10.1002/ana.21535 18. Rubinsztein DC, 2006, The roles of intracellular protein-
degradation pathways in neurodegeneration. Nature,
9. Liu R, Gao X, Lu Y, et al., 2011, Meta-analysis of the 443: 780 – 786.
relationship between Parkinson disease and melanoma.
Neurology, 76: 2002 – 2009. https://doi.org/10.1038/nature05291
https://doi.org/10.1212/wnl.0b013e31821e554e 19. Pan T, Kondo S, Le W, et al., 2008, The role of autophagy-
lysosome pathway in neurodegeneration associated with
10. Devine MJ, Plun-Favreau H, Wood NW, 2011, Parkinson’s Parkinson’s disease. Brain, 131: 1969 – 1978.
disease and cancer: Two wars, one front. Nat Rev Cancer,
11: 812 – 823. https://doi.org/10.1093/brain/awm318
https://doi.org/10.1038/nrc3150 20. Duffy DL, Zhao ZZ, Sturm RA, et al., 2010, Multiple
pigmentation gene polymorphisms account for a substantial
11. Law MH, Bishop DT, Lee JE, et al., 2015, Genome-wide proportion of risk of cutaneous malignant melanoma.
meta-analysis identifies five new susceptibility loci for J Invest Dermatol, 130: 520 – 528.
cutaneous malignant melanoma. Nat Genet, 47: 987 – 995.
https://doi.org/10.1038/jid.2009.258
https://doi.org/10.1038/ng.3373
21. Halaban R, Cheng E, Zhang Y, et al., 1997, Aberrant retention
12. Chen X, Chen H, Cai W, et al., 2017, The melanoma-linked of tyrosinase in the endoplasmic reticulum mediates
“redhead” MC1R influences dopaminergic neuron survival. accelerated degradation of the enzyme and contributes to
Ann Neurol, 81: 395 – 406.
the dedifferentiated phenotype of amelanotic melanoma
https://doi.org/10.1002/ana.24852 cells. Proc Natl Acad Sci U S A, 94: 6210 – 6215.
13. Bose A, Petsko GA, Eliezer D, 2018, Parkinson’s disease and https://doi.org/10.1073/pnas.94.12.6210
melanoma: Co-occurrence and mechanisms. J Parkinsons 22. Gudbjartsson DF, Sulem P, Stacey SN, et al., 2008, ASIP
Dis, 8: 385 – 398.
and TYR pigmentation variants associate with cutaneous
https://doi.org/10.3233/JPD-171263 melanoma and basal cell carcinoma. Nat Genet, 40: 886 – 891.
14. Dean DN, Lee JC, 2020, Defining an amyloid link between https://doi.org/10.1038/ng.161

Volume 1 Issue 1 (2023) 6 https://doi.org/10.36922/jcbp.0571